Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma
Clinical trial NCT00401817 · COMPLETED
Trial details
- NCT number
- NCT00401817
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2011-07-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.